Cholecystokinin-assisted hydrodissection of the gallbladder fossa during FDG PET/CT-guided liver ablation. uri icon

Overview

abstract

  • A 68-year-old female with colorectal cancer developed a metachronous isolated fluorodeoxyglucose-avid (FDG-avid) segment 5/6 gallbladder fossa hepatic lesion and was referred for percutaneous ablation. Pre-procedure computed tomography (CT) images demonstrated a distended gallbladder abutting the segment 5/6 hepatic metastasis. In order to perform ablation with clear margins and avoid direct puncture and aspiration of the gallbladder, cholecystokinin was administered intravenously to stimulate gallbladder contraction before hydrodissection. Subsequently, the lesion was ablated successfully with sufficient margins, of greater than 1.0 cm, using microwave with ultrasound and FDG PET/CT guidance. The patient tolerated the procedure very well and was discharged home the next day.

publication date

  • July 10, 2013

Research

keywords

  • Catheter Ablation
  • Cholecystokinin
  • Gallbladder
  • Liver Neoplasms
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed

Identity

Scopus Document Identifier

  • 84888202843

Digital Object Identifier (DOI)

  • 10.1007/s00270-013-0692-1

PubMed ID

  • 23839009

Additional Document Info

volume

  • 36

issue

  • 6